文献速递围术期管理与 ERAS

主动脉弓杂交与全腔内修复术综述

Hybrid and total endovascular repair of the aortic arch.
PubMed 文献 · Br J Surg · 2018-01-01

该综述基于MEDLINE和Embase检索,聚焦主动脉弓腔内修复。杂交弓修复早期死亡率约12%,卒中风险高达15%,但开放手术仍是年轻适合患者的金标准。全腔内修复短期结果可接受,长期数据待积累。

要点

  • 杂交弓修复早期死亡率约12%,卒中风险高达15%。
  • 杂交修复远期免于破裂或再干预率显著较低。
  • 开放弓修复仍是年轻、适合患者的标准治疗。

核心结论

  • 主动脉弓病变修复对腔内技术是巨大挑战,开放手术仍是年轻适合患者的标准。

研究设计与样本

  • 综述,通过MEDLINE和Embase检索主动脉弓管理相关研究,聚焦腔内修复。

主要发现

  • 尽管杂交修复患者总体围术期风险更高,其并发症率和早期死亡率与开放弓置换相当。
  • 杂交修复远期免于主动脉破裂或再干预率显著较低,归因于内漏发生。
  • 全腔内弓修复在急诊可采用平行支架或原位开窗,择期可采用定制装置(扇形、开窗或分支支架)。
  • 这些较新技术的报告显示可接受的短期结果,但长期数据仍需等待。

临床怎么用

  • 年轻、适合患者仍以开放主动脉弓修复为标准。
  • 杂交弓修复可用于较高围术期风险患者,但需注意卒中、截瘫、逆行夹层和内漏风险。
  • 全腔内弓修复的短期结果可接受,但长期疗效待证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent advances in endovascular technology have enabled minimally invasive repair of the aortic arch, with specifically designed stent-grafts. This article reviews hybrid and total endovascular repair in the management of aortic arch pathology. METHODS: Studies relating to aortic arch management were identified using MEDLINE and Embase, focusing on endovascular repair. RESULTS: Hybrid arch repair is associated with an early mortality rate of some 12 per cent, and carries significant risk of stroke (up to 15 per cent), paraplegia (up to 6 per cent), retrograde dissection (up to 6·5 per cent) and proximal endoleak (6 per cent). Despite patients being of overall higher perioperative risk, hybrid repair has morbidity and early mortality rates comparable to those of open arch replacement. However, rates of freedom from aortic rupture or reintervention are significantly lower in the longer term, owing to the incidence of endoleak. Total endovascular arch repair may be achieved by the use of parallel stents or in situ fenestration in the emergency setting, or use of custom-made devices (scalloped, fenestrated or branched stent-grafts) in the elective setting. Reports of these relatively novel technologies suggest acceptable short-term outcomes, but long-term data are still awaited. CONCLUSION: Repair of aortic arch pathology presents a formidable challenge for endovascular technology. Open aortic arch repair remains the standard in younger, fitter patients, but endovascular technology and experience continue to evolve with encouraging early outcomes and expanding indications.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Rudarakanchana N, Jenkins MP. Hybrid and total endovascular repair of the aortic arch. Br J Surg. 2018. PMID: 29488648. doi:10.1002/bjs.10713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。